NL-OMON21418已完成不适用
A double blind, placebo controlled study to assess the safety and efficacy of PCD-04 as a protective agent against anthracycline-induced cardiotoxicity.
TT Bio-Pharma Co.Ltd.Atago Green Hills MORI Tower 26F2-5-1, AtagoMinato-ku, Tokyo 105-6201 Japan0 个研究点目标入组 72 人开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- 入组人数
- 72
研究概览
简要总结
/A
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •1. Female;
排除标准
- •1. Patients with indication of distant metastases of breast carcinoma;
研究者
相似试验
招募中
不适用
Het effect van fenretinide op insulinegevoeligheid.ObesityMetabolic syndrome XInsulin resistanceFatty liverNL-OMON25232Academic Medical Center (AMC)20
已完成
不适用
Alfentanil in CT-colonography.PainCt-colonographyColorectal cancerPolypsNL-OMON25320Academic Medical Center90
已完成
不适用
Efficacy and safety of ezetimibe in young children with familial hypercholesterolemia.Familial hypercholesterolemiaNL-OMON25426Academic Medical Centre (AMC), Department of Vascular Medicine70
招募中
不适用
Magnesium oxide to reduce prostate motion.1. Prostate cancer<br />2. radiotherapy.<br />(NLD: prostaatkanker, bestraling).NL-OMON24191niversity Medical Center Utrecht, The Netherlands184
招募中
不适用
The FCATFibromyalgiaNL-OMON28585eiden University Medical Center (LUMC)40